Bendamustine Ethyl Ester
| Product Name | Bendamustine Ethyl Ester |
|---|---|
| Alternate Names | Bendamustine Impurities, Impurities of Bendamustine |
| CAT No. | CS-O-07339 |
| CAS No. | 87475-54-5 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 386.32 g/mol |
| Mol. For. | C₁₈H₂₅Cl₂N₃O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bendamustine |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CCOC(=O)CCCC1=NC2=C(N1C)C=CC(=C2)N(CCCl)CCCl |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bendamustine Ethyl Ester is an anti-cancer medication that is used to treat a variety of cancers, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and multiple myeloma. It is a prodrug of bendamustine, which means that it is converted into the active form of the drug in the body. Bendamustine Ethyl Ester works by interfering with the growth and division of cancer cells, ultimately leading to their destruction.
Chemically speaking, Bendamustine Ethyl Ester is a nitrogen mustard derivative. It is structurally similar to other alkylating agents, which are a class of drugs that are used to treat cancer. Bendamustine Ethyl Ester contains two functional groups, an ethyl ester and a benzimidazole ring. The ethyl ester group makes the drug more lipophilic, which helps it to cross cell membranes more easily. The benzimidazole ring is responsible for the drug's anti-cancer activity.
Bendamustine Ethyl Ester is typically administered intravenously, either alone or in combination with other chemotherapy drugs. The dosage and duration of treatment depend on the type of cancer being treated, as well as the patient's overall health and medical history. Common side effects of the drug include nausea, vomiting, fatigue, and low blood cell counts. In rare cases, more serious side effects such as allergic reactions, liver toxicity, or lung problems may occur. Overall, Bendamustine Ethyl Ester is an effective and well-tolerated treatment option for many cancer patients.
Get an Instant Quote
Related Compounds
Bendamustine D-Mannitol Ester | Bendamustine Isopropyl Ester HCl | Bendamustine Impurity 1 | Bendamustine Trihydroxy Dimer Impurity | Bendamustine Related Compound G | Bendamustine Impurity 10 HCl salt | Bendamustine USP Related Compound A | Dideschloroethyl Bendamustine | Bendamustine Methyl Ester (HCl) | Bendamustine Monohydroxy Acid Impurity | Bendamustine Related Impurity 3 | Bendamustine Deschloroethyl Acid Ethyl Ester | Dihydroxy Bendamustine | Bendamustine Related Compound B | Bendamustine Impurity D | Bendamustine PEG ester mixture | Bendamustine Deschloroethyl Acid Impurity | Bendamustine Impurity 14 HCl salt | Bendamustine Related Impurity 17 | Bendamustine Propylene Glycol Ester 1 | Bendamustine Isopropyl Ester Impurity | Deschloroethyl Bendamustine ethynylamide impurity | Bendamustine Ethyl Impurity | Bendamustine USP Related Compound I (HCl) | Bendamustine Related Compound D(Secondary Standards traceble to USP) | Bendamustine Impurity B | Bendamustine Monohydroxy Isopropyl Ester Impurity | Bendamustine Ether Impurity | Bendamustine Chloro Dimer Impurity | Bendamustine Related Impurity 4 | Bendamustine Methyl Ester | Deschloroethyl bendamustine | Bendamustine Impurity HCl salt | Bendamustine Dideschloroethyl Ethyl Ester | Bendamustine Monohydroxy Impurity | Bendamustine N-Alkylated Impurity Hydrochloride | N-Nitroso Bendamustine Impurity | Bendamustine Impurity C | Bendamustine Nitro Ethyl Ester Impurity |